Four of the 132 patients treated with Varipulse in the first two months of the U.S. launch had a form of stroke shortly after surgery.

A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the ...

We recently compiled a list of the 12 Best Psychedelic Stocks to Buy in 2025. In this article, we are going to take a look at where Johnson & Johnson (NYSE:JNJ) stands against the other psychedelic ...

Johnson & Johnson is well-diversified across thriving healthcare segments, with promising FDA approvals. Read why I assign a ...

Bryan Johnson, the American entrepreneur renowned for his anti-ageing endeavours, has disclosed the details of his latest ...

Johnson & Johnson announced data from the Phase 3 ASTRO study of TREMFYA subcutaneous, SC, induction therapy in adults with moderately to ...

Johnson & Johnson (JNJ) stock in focus as limited rollout of Varipulse heart device resumes after a safety review prompted by neurovascular events. Read more here.

The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an ...

The group representing medical device makers in Washington is coming out against the Trump administration’s firings of ...

CEO Geoff Martha said Medtronic would submit its application for urological procedures to the Food and Drug Administration by ...

A class action filed today says Kiwis have been deceived for about two decades through the use of phenylephrine in cold and ...

Mr Johnson is an American entrepreneur and venture capitalist, best known for his anti-aging attempt that he refers to as ...